Home Antibody All anti-CDKN2B antibodies
Also for CDKN2B (NM_004936)
|The antiserum was produced against synthesized peptide derived from human p15 INK antibody.|
|Human, Mouse, Rat
|WB, IHC, IF
||WB: 1:500~1:3000, IHC: 1:50~1:100, IF: 1:100~1:500, ELISA: 1:5000
|Phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.|
|The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
|p15 INK antibody detects endogenous levels of total p15 INK protein.
|Homo sapiens cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) (CDKN2B), transcript variant 1|
|CDK4I; INK4B; MTS2; P15; p15INK4b; TP15|
TGF Beta Signaling Pathway
* Shipping is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
Western blot analysis of extracts from HeLa cells, using p15 INK antibody (#TA312926).The lane on the right is treated with the synthesized peptide.Western blot analysis of extracts from 293 cells (Lane 2), using p15 INK Antibody. The lane on the left is treated with synthesized peptide.
Immunohistochemical analysis of paraffin-embedded human lung carcinoma tissue using p15 INK antibody (#TA312926).The picture on the right is treated with the synthesized peptide.
Immunofluorescence analysis of HeLa cells, using p15 INK antibody (#TA312926).The picture on the right is treated with the synthesized peptide.